Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Thoracic Neoplasms and KRAS[original query] |
---|
Clinicopathological features of younger (aged ? 50 years) lung adenocarcinoma patients harboring the EML4-ALK fusion gene. Thoracic cancer 2018 Mar . Kometani Takuro, Sugio Kenji, Osoegawa Atsushi, Seto Takashi, Ichinose Yuki |
Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation. Thoracic cancer 2019 11 11 (1): 140-149. Hayakawa Daisuke, Takahashi Fumiyuki, Mitsuishi Yoichiro, Tajima Ken, Hidayat Moulid, Winardi Wira, Ihara Hiroaki, Kanamori Koichiro, Matsumoto Naohisa, Asao Tetsuhiko, Ko Ryo, Shukuya Takehito, Takamochi Kazuya, Hayashi Takuo, Suehara Yoshiyuki, Takeda Nakamura Ikuko, Ueno Toshihide, Kohsaka Shinji, Mano Hiroyuki, Takahashi Kazuhi |
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes. Thoracic cancer 2019 Oct . Meijer Tineke W H, Looijen-Salamon Monika G, Lok Jasper, van den Heuvel Michel, Tops Bastiaan, Kaanders Johannes H A M, Span Paul N, Bussink Joh |
Status of 10 targeted genes of non-small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution. Thoracic cancer 2020 Jul . Li Dan, Ding Li, Ran Wenwen, Huang Yan, Li Guangqi, Wang Chengqin, Xiao Yujing, Wang Xiaonan, Lin Dongliang, Xing Xiaomi |
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer. Thoracic cancer 2020 Apr . Wei Xue-Wu, Gao Xin, Zhang Xu-Chao, Yang Jin-Ji, Chen Zhi-Hong, Wu Yi-Long, Zhou Qi |
Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report. Thoracic cancer 2020 2 11 (4): 1094-1098. Tang Yong, Li Yadan, Zhang Lei, Tong Guihui, Ou Zhu'an, Wang Zhuocai, Zhang Henghui, Qiao Guib |
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status. Thoracic cancer 2020 Feb . Arrieta Oscar, Ramírez-Tirado Laura-Alejandra, Caballé-Perez Enrique, Mejia-Perez Alberto, Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Lozano-Ruíz Francisco, Segura-González Manuel, Cruz-Rico Graciela, Maldonado Federico, Rosell Rafa |
Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418). Thoracic cancer 2020 Dec . Mascarenhas Eldsamira, Gelatti Ana Caroline, Araújo Luiz Henrique, Baldotto Clarissa, Mathias Clarissa, Zukin Mauro, Werutsky Gustavo, Pacheco Patricia, Gomes Rafaela, de Castro Gilberto, Cordeiro de Lima Vladmir Cláud |
Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancer. Thoracic cancer 2020 12 12 (3): 357-363. Si Xiaoyan, Pan Ruili, Ma Shaohua, Li Lin, Liang Li, Zhang Ping, Chu Yuping, Wang Hanping, Wang Mengzhao, Zhang Xiaotong, Zhang |
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis. Thoracic cancer 2021 Feb . Kobayashi Nobuaki, Katakura Seigo, Kamimaki Chisato, Somekawa Kohei, Fukuda Nobuhiko, Tanaka Katsushi, Watanabe Keisuke, Horita Nobuyuki, Hara Yu, Piao Hongmei, Kaneko Takes |
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer. Thoracic cancer 2022 Oct . de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu |
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy. Thoracic cancer 2023 9 . Yoshiaki Amino, Siew-Kee Low, Hironori Ninomiya, Ayu Kiritani, Keiki Miyadera, Sho Kakuto, Takahiro Akita, Ryosuke Tsugitomi, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Noriko Yanagitani, Makoto Nish |
RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma. Thoracic cancer 2023 4 . Li Hong-Shuai, Liu Cheng-Ming, Wang Y |
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: